Effective knowledge management in translational medicine

<p>Abstract</p> <p>Background</p> <p>The growing consensus that most valuable data source for biomedical discoveries is derived from human samples is clearly reflected in the growing number of translational medicine and translational sciences departments across pharma a...

Full description

Bibliographic Details
Main Authors: Khasanova Tatiana, Koka Venkata, Szalma Sándor, Perakslis Eric D
Format: Article
Language:English
Published: BMC 2010-07-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/8/1/68
id doaj-27e1fffb274c41c28d7755a6aad98254
record_format Article
spelling doaj-27e1fffb274c41c28d7755a6aad982542020-11-24T23:27:18ZengBMCJournal of Translational Medicine1479-58762010-07-01816810.1186/1479-5876-8-68Effective knowledge management in translational medicineKhasanova TatianaKoka VenkataSzalma SándorPerakslis Eric D<p>Abstract</p> <p>Background</p> <p>The growing consensus that most valuable data source for biomedical discoveries is derived from human samples is clearly reflected in the growing number of translational medicine and translational sciences departments across pharma as well as academic and government supported initiatives such as Clinical and Translational Science Awards (CTSA) in the US and the Seventh Framework Programme (FP7) of EU with emphasis on translating research for human health.</p> <p>Methods</p> <p>The pharmaceutical companies of Johnson and Johnson have established translational and biomarker departments and implemented an effective knowledge management framework including building a data warehouse and the associated data mining applications. The implemented resource is built from open source systems such as i2b2 and GenePattern.</p> <p>Results</p> <p>The system has been deployed across multiple therapeutic areas within the pharmaceutical companies of Johnson and Johnsons and being used actively to integrate and mine internal and public data to support drug discovery and development decisions such as indication selection and trial design in a translational medicine setting. Our results show that the established system allows scientist to quickly re-validate hypotheses or generate new ones with the use of an intuitive graphical interface.</p> <p>Conclusions</p> <p>The implemented resource can serve as the basis of precompetitive sharing and mining of studies involving samples from human subjects thus enhancing our understanding of human biology and pathophysiology and ultimately leading to more effective treatment of diseases which represent unmet medical needs.</p> http://www.translational-medicine.com/content/8/1/68
collection DOAJ
language English
format Article
sources DOAJ
author Khasanova Tatiana
Koka Venkata
Szalma Sándor
Perakslis Eric D
spellingShingle Khasanova Tatiana
Koka Venkata
Szalma Sándor
Perakslis Eric D
Effective knowledge management in translational medicine
Journal of Translational Medicine
author_facet Khasanova Tatiana
Koka Venkata
Szalma Sándor
Perakslis Eric D
author_sort Khasanova Tatiana
title Effective knowledge management in translational medicine
title_short Effective knowledge management in translational medicine
title_full Effective knowledge management in translational medicine
title_fullStr Effective knowledge management in translational medicine
title_full_unstemmed Effective knowledge management in translational medicine
title_sort effective knowledge management in translational medicine
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2010-07-01
description <p>Abstract</p> <p>Background</p> <p>The growing consensus that most valuable data source for biomedical discoveries is derived from human samples is clearly reflected in the growing number of translational medicine and translational sciences departments across pharma as well as academic and government supported initiatives such as Clinical and Translational Science Awards (CTSA) in the US and the Seventh Framework Programme (FP7) of EU with emphasis on translating research for human health.</p> <p>Methods</p> <p>The pharmaceutical companies of Johnson and Johnson have established translational and biomarker departments and implemented an effective knowledge management framework including building a data warehouse and the associated data mining applications. The implemented resource is built from open source systems such as i2b2 and GenePattern.</p> <p>Results</p> <p>The system has been deployed across multiple therapeutic areas within the pharmaceutical companies of Johnson and Johnsons and being used actively to integrate and mine internal and public data to support drug discovery and development decisions such as indication selection and trial design in a translational medicine setting. Our results show that the established system allows scientist to quickly re-validate hypotheses or generate new ones with the use of an intuitive graphical interface.</p> <p>Conclusions</p> <p>The implemented resource can serve as the basis of precompetitive sharing and mining of studies involving samples from human subjects thus enhancing our understanding of human biology and pathophysiology and ultimately leading to more effective treatment of diseases which represent unmet medical needs.</p>
url http://www.translational-medicine.com/content/8/1/68
work_keys_str_mv AT khasanovatatiana effectiveknowledgemanagementintranslationalmedicine
AT kokavenkata effectiveknowledgemanagementintranslationalmedicine
AT szalmasandor effectiveknowledgemanagementintranslationalmedicine
AT perakslisericd effectiveknowledgemanagementintranslationalmedicine
_version_ 1725552485634932736